Karen L. Smith MD, PhD, MBA, LLM
Board Member
Skye Bioscience, Inc. (SKYE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karen L. Smith MD, PhD, MBA, LLM
Karen L. Smith MD, PhD, MBA, LLM is recorded as Board Member at Skye Bioscience, Inc. (SKYE). Skye Bioscience, Inc. reported in an 8-K filed July 3, 2024 that Karen L. Smith MD, PhD, MBA, LLM was appointed director, effective July 2, 2024.
“On July 2, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Skye Bioscience, Inc. (the "Company"), the Board approved an increase in its authorized size from eight to nine members and appointed Karen L. Smith MD, PhD, MBA, LLM to fill the vacancy created by such increase.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Skye Bioscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Lisa Anson CEO
- Punit Dhillon CEO, Chief Accounting Officer, Board Member
- Paul Grayson Chairman, Board Member
- Elena Traistaru CFO
- Kaitlyn Arsenault CFO
- Peter Collum CFO
- Tu Diep COO
- Dr. Cliff Jones CTO
- Richard Janney Chief Accounting Officer
- Andrew J. Schwab Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.